Triethylenethiophosphoramide (thiotepa) is an alkylating agent known to cross-link DNA and prevent cells from replicating. Thiotepa has a low molecular weight (189 kDa), which enables it to be ...

In the meantime current gene therapies remain expensive and challenging to scale up because each patient’s batch of cells has ...

Mangaluru: A medical procedure was performed recently at Zulekha Yenepoya Institute of Oncology, marking the first-ever high-dose Thiotepa-based bone marrow transplant for brain lymphoma at the ...

The goal of HCT is to cure an underlying malignancy or hematologic disorder. The procedure can be performed in an inpatient ...

ICCG High Dose Study Randomised trial of high dose therapy using cyclophosphamide, thiotepa and carboplatin in primary breast cancer patients with 4 or more histologically involved positive nodes.

Expert Rev Anticancer Ther. 2013;13(11):1281-1295. The extended template comprises the standard package with the addition of presacral area, the proximal common iliac and aortic bifurcation. The ...

This is the first comprehensive immunohistochemical analysis of the expression of several class I HDAC proteins (1, 2 and 3) in urothelial carcinoma. In our study, we found all three isoforms in a ...